Iceland Cancer Research
World's Most Complete Genetic Database & Precision Medicine Pioneer
Population Genome Mapped
World's only
Years Cancer Registry
Since 1955
Pediatric Cancer Survival
World-class outcomes
World's Most Comprehensive Genetic Database
Iceland has mapped the genomes of 100% of its population, creating the world's most complete genetic cancer research database. This enables unprecedented insights into hereditary cancer risk.
Impact:
Identifying genetic cancer risk factors for global populations
BRCA Gene Discovery for Cancer Prevention
Icelandic researchers discovered multiple BRCA gene variants linked to breast, ovarian, and prostate cancers, enabling early screening and prevention in high-risk families.
Impact:
Saving thousands through early detection and prevention
100% Cancer Registry Coverage
Iceland's cancer registry has tracked 100% of cancer cases since 1955, providing unparalleled long-term outcome data for 70+ years.
Impact:
World's most complete cancer outcome tracking
Precision Medicine Population Study
Iceland's entire population participates in genomic medicine, making it the world's first nation to implement nationwide precision oncology.
Impact:
Model for national precision cancer care
Cancer-Free Families Research
Iceland's genealogical records spanning 1,000+ years enable researchers to study why certain families never develop cancer, revealing protective genetic factors.
Impact:
Understanding genetic cancer resistance
Arctic Environmental Cancer Research
Iceland studies how extreme Arctic conditions, diet (high omega-3), and lifestyle affect cancer development, providing insights for northern populations worldwide.
Impact:
Tailoring cancer prevention for Arctic populations
Pediatric Cancer Survival Excellence
Iceland achieves 90%+ survival rates for childhood cancers through early detection, rapid treatment access, and comprehensive family support.
Impact:
World-class pediatric oncology outcomes
Cancer Screening Universal Coverage
Iceland provides free cancer screening (breast, cervical, colorectal) to 100% of its population, achieving near-perfect participation rates.
Impact:
Catching cancer early in entire population
deCODE genetics (now part of Amgen)
Reykjavik
World-leading human genetics research company. Mapped entire Icelandic genome. Pioneering precision medicine and cancer genetic risk prediction.
Key Specialties:
Landspitali University Hospital
Reykjavik
Iceland's national hospital and only comprehensive cancer center. Excellence in precision oncology, pediatric cancer, and universal care.
Key Specialties:
University of Iceland - Faculty of Medicine
Reykjavik
Leading research on cancer genetics, Arctic health, and environmental factors in cancer development.
Key Specialties:
Iceland's unique genetic database attracts global cancer researchers
Population-Wide Precision Oncology Program
Nationwide program tailoring cancer treatments based on genomic profiling for all Icelandic cancer patients.
BRCA Preventive Screening Study
Universal screening program for BRCA gene mutations enabling early detection and prevention in high-risk families.
Arctic Diet & Cancer Prevention
Long-term study on how traditional Icelandic diet (high omega-3, fermented foods) affects cancer risk and outcomes.
Registry-listed trials for Iceland currently tracked in our database, sourced from public trial registries.